The COVID-19 pandemic led to heightened public interest in learning about viruses and how they can cause diseases. There has ...
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...
A new study has revealed that individuals who have recovered from Covid-19 face double the risk of experiencing severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback